Protective effect of NAC preconditioning against ischemia-reperfusion injury in piglet small bowel transplantation: Effects on plasma TNF, IL-8, hyaluronic acid, and NO

Journal of Surgical Research

Volumn 168, Issue 2, 2011, Pages 301-305

  Kostopanagiotou, Georgia ^a   Avgerinos, Efthimios D ^b   Markidou, Efthimia ^a   Voiniadis, Panagiotis ^b   Chondros, Constantinos ^b   Theodoraki, Kassiani ^b   Smyrniotis, Vassilios ^b   Arkadopoulos, Nikolaos ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

hyaluronic acid; IL 8; ischemia reperfusion; NO; small bowel transplantation; TNF

Indexed keywords

ACETYLCYSTEINE; HYALURONIC ACID; INTERLEUKIN 8; LACTATE DEHYDROGENASE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENTERITIS; ENZYME BLOOD LEVEL; FEMALE; INTESTINE INJURY; INTESTINE ISCHEMIA; INTESTINE TRANSPLANTATION; ISCHEMIA REPERFUSION INJURY; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; PIGLET; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; STOMACH PROTECTION;

EID: 79955853928     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.09.002     Document Type: Article

References (40)

1. Ruiz P, Kato T, Tzakis A. Current status of transplantation of the small intestine. Transplantation 2007;83:1.
2. Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 2001;94:1133.
3. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159.
4. Adams AB, Larsen CP, Pearson TC, et al. The role of TNF receptor and TNF superfamily molecules in organ transplantation. Am J Transplant 2002;2:12.
5. McDiarmid SV, Farmer DG, Kuniyoshi JS, et al. The correlation of intragraft cytokine expression with rejection in rat small intestine transplantation. Transplantation 1994;58:690.
6. 2. J Surg Res 2008;147:108.
7. Harward TR, Brooks DL, Flynn TC, et al. Multiple organ dysfunction after mesenteric artery revascularization. J Vasc Surg 1993;18:459.
8. Moore-Olufemi SD, Kozar RA, Moore FA, et al. Ischemic preconditioning protects against gut dysfunction and mucosal injury after ischemia/reperfusion injury. Shock 2005;23:258.
9. Avgerinos ED, Kostopanagiotou G, Costopanagiotou C, et al. Intestinal preconditioning ameliorates ischemia-reperfusion induced acute lung injury in rats: An experimental study. J Surg Res 2009 Jan 14 [Epub ahead of print].
10. Ito K, Ozasa H, Kojima N, et al. Pharmacological preconditioning protects lung injury induced by intestinal ischemia/reperfusion in rat. Shock 2003;19:462.
11. Oltean M, Mera S, Olofsson R, et al. Transplantation of preconditioned intestinal grafts is associated with lower inflammatory activation and remote organ injury in rats. Trans Proc 2006;38:1775.
12. Fukuzawa K, Emre S, Senyuz O, et al. N-Acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation 1995;59:6.
13. Stamler J, Mendelsohn ME, Amarante P, et al. N-Acetylcysteine potentates platelet inhibition by endothelium derived relaxing factor. Circ Res 1989;65:789.
14. Sprong RC, Winkelhuyzen-Janssen AML, Aarsman CJM, et al. Low-dose N-Acetylcysteine protects rats against endotoxin-mediated oxidative stress, but high dose increases mortality. Am J Respir Crit Care Med 1998;157:1283.
15. Nakano H, Boudjema K, Alexandre E, et al. Protective effects of N-acetylcysteine on hypothermic ischemia-reperfusion injury of rat liver. Hepatology 1995;22:539.
16. Nagasaki H, Nakano H, Boudjema K, et al. Efficacy of preconditioning with N-acetylcysteine against reperfusion injury after prolonged cold ischemia in rats liver in which glutathione had been reduced by buthionine sulphoximine. Eur J Sur 1998; 164:139.
17. Tsuji F, Miyake Y, Aono H, et al. Effects of bucillamine and N-acetylcysteine on cytokine production and collagen-induced arthritis. Clin Exp Immunol 1999;115:26.
18. Verhasselt V, Vanden Berghe W, et al. N-acetylcysteine inhibits primary human T cell responses at the dendritic cell level: Association with NF-κB inhibition. J Immunol 1999;162:2569.
19. Cuzzocrea S, Mazzon E, Costantino G, et al. Effects of N-acetylcysteine in a rat model of ischemia reperfusion injury. Cardiovasc Res 2000;47:537.
20. Kostopanagiotou G, Tierris J, Arkadopoulos N, et al. Liver transplantation in pigs: NO, oxygen free radicals, pulmonary hemodynamics. J Surg Res 2008;149:231.
21. Mueller AR, Platz KP, Heckert C, et al. The extracellular matrix: An early target of preservation/reperfusion injury and acute rejection after small bowel transplantation. Transplantation 1998; 65:770.
22. Sonnino RE, Riddle JM, Pritchard TJ. Grading system for histologic changes in rat small bowel transplants. Transplant Proc 1992;24:1201.
23. Hur GM, Ryu YS, Yun HY, et al. Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-kB. Biochem. Biophys Res Com 1999;261:917.
24. Spapen H, Zhang H, Demanet C, et al. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest 1998;113:1616.
25. Weigand MA, Plachky J, Thies JC, et al. N-Acetylcysteine attenuates the increase in a-glutathione S-transferase and circulating ICAM-1 and VCAM-1 after reperfusion in humans undergoing liver transplantation. Transplantation 2001;72:694.
26. Stamler J, Mendelsohn ME, Amarante P, et al. N-Acetylcysteine potentates platelet inhibition by endothelium-derived relaxing factor. Circ Res 1989;65:789.
27. Yadav SS, Howell DN, Steeber DA, et al. P-selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 1999;29:1494.
28. Cuzzocrea S, Chatterjee P, Mazzon E, et al. Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury. Shock 2002;18:169.
29. Cuzzocrea S, Zingarelli B, Caputi AP. Role of constitutive nitric oxide synthase and peroxynitrite production in a rat model of splanchnic artery occlusion shock. Life Sci 1998;63:789.
30. Sola A, De Oca J, Gonzalez R, et al. Protective effect of ischemic preconditioning on cold preservation and reperfusion injury associated with rat intestinal transplantation. Ann Surg 2001; 234:98.
31. Battista S, Mengozzi G, Bar F, et al. Nitric oxide level profile in human liver transplantation. Dig Dis Sci 2002;47:528.
32. Varadarajan R, Golden-Mason L, Young L, et al. Nitric oxide in early ischemia reperfusion injury during human orthotopic liver transplantation. Transplantation 2004;78:250.
33. Gerdin B, Hallgren R. Localisation of hyaluran in the human intestinal wall. Gut 1991;32:760.
34. Mueller AR, Rao PN, Snyder JT, et al. Hyaluronic acid and purine nucleoside phosphorylase in vascular and luminal effluents of small bowel grafts as parameters of preservation injury. Transplantation 1993;55:1225.
35. Hamura Y, Ito A, Okada Y, et al. Hyaluronic acid metabolism in inflamed mesenterium of guinea pig. Res Commun Chem Pathol Pharmacol 1989;66:311.
36. Levay-Young B, Gruessner SE, Shearer JD, et al. Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation with and without donor-specific cell augmentation. J Surg Res 2003;114:78.
37. Tsuruma T, Yagihashi A, Hirata K, et al. Evaluation of plasma IL-8 (CINC) concentration during ischemia and after reperfusion in the small intestine. Transplant Proc 1996;28:1917.
38. Song WL, Wang WZ, Wu GS, et al. Diagnosis and treatment of acute rejection in the first case of human living-related small bowel transplantation with a long-term survival in China. World J Gastroenterol 2005;11:5332.
39. Ivey CL, Williams FM, Collins PD, et al. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit: Evidence for a role for C5a and interleukin-8. J Clin Invest 1995;95:2720.
40. Wuyts WA, Vanaudenaerde BM, Dupont LJ, et al. N-Acetylcysteine inhibits interleukin-17-induced interleukin-8 production from human airway smooth muscle cells: A possible role for anti-oxidative treatment in chronic lung rejection? Transplant 2005;24:875.